Drug intelligence / Profile preview

cordycepin

Development stage
Phase 2
Lead developer
OncoVista Innovative Therapies
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Cordycepin is a purine nucleoside antimetabolite and antibiotic originally isolated from the fungus *Cordyceps militaris*. Also known as 3’-deoxyadenosine, it is structurally similar to adenosine but lacks a hydroxyl group at the 3' position of its ribose moiety. Cordycepin exhibits a broad spectrum of biological activities, including antitumor, antioxidant, anti-inflammatory, immunomodulatory, antiviral, and metabolic regulatory effects[1][4][5]. Its mechanism of action involves inhibition of RNA synthesis by acting as an adenosine analog and incorporation into RNA chains; this leads to premature termination of transcription[4][5]. Additionally, cordycepin acts as a pro-drug that activates AMP-activated protein kinase (AMPK) after being metabolized intracellularly into cordycepin monophosphate[6]. This activation influences cellular energy metabolism and has been linked to beneficial effects in cancer cell apoptosis (via mitochondrial pathways), metabolic disorders such as diabetes and hyperlipidemia, immune modulation (including both immunostimulatory and immunosuppressive actions), and potential use in autoimmune diseases or transplant rejection management[1][5][6][8].

Other names
3'-deoxyadenosine9-(3-deoxy-β-D-ribofuranosyl)adenine
02

Targets

RNAP (Bacterial dna-dependent RNA polymerase)AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on cordycepin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cordycepin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call